Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04991948
Title Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Celyad Oncology SA

rectum adenocarcinoma

colon adenocarcinoma


Fluorouracil + Leucovorin + NKR-2 cells + Oxaliplatin + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA | BEL

Additional content available in CKB BOOST